Here's Why You Should Retain DuPont Stock in Your Portfolio

10.01.25 13:45 Uhr

Werte in diesem Artikel
Aktien

73,27 EUR -1,12 EUR -1,51%

Indizes

6.066,4 PKT 40,5 PKT 0,67%

DuPont de Nemours, Inc. DD benefits from its innovation-driven investment, productivity actions and the acquisitions of the Spectrum Plastics Group and Donatelle Plastics amid headwinds from weaker demand in specific businesses.DD’s shares are down 2.3% in a year compared with the Zacks Chemicals Diversified industry’s 12.3% decline.Image Source: Zacks Investment ResearchLet’s find out why DD stock is worth retaining at the moment.DuPont Gains on Productivity, Innovation & AcquisitionDuPont remains focused on driving growth through innovation and new product development. Its innovation-driven investment is focused on several high-growth areas. DD remains committed to driving returns from its R&D investment.The company, in August 2023, completed the buyout of a leading manufacturer of specialty medical devices and components, Spectrum Plastics Group, from AEA Investors for $1.75 billion. The acquisition strengthened DuPont’s existing position in stable and fast-growing healthcare end markets. It is also in sync with its focus on high-growth, customer-driven innovation for the healthcare market.The buyout of Donatelle Plastics also enhances DD’s exposure in healthcare, expanding its expertise in the medical device market segments. The acquisition introduces complementary advanced technologies and capabilities, such as medical device injection molding, liquid silicone rubber processing, precision machining, device assembly and tool building.DuPont is also benefiting from cost synergy savings and productivity improvement actions. The benefits of its structural cost actions are expected to be realized in 2024. DD also continues to implement strategic price increases in the wake of cost inflation. These actions are likely to support its results. DuPont is also executing additional restructuring actions and expects annualized cost savings of $150 million from these measures.DuPont, in May 2024, announced a strategic plan to separate into three distinct, publicly traded companies to unlock value for shareholders and enhance operational focus. The proposed separations of the Electronics and Water businesses will be executed in a tax-free manner for DuPont shareholders, resulting in New DuPont, Electronics and Water as independent entities. Each company will benefit from increased agility and focus within their respective industries while maintaining strong balance sheets and attractive financial profiles. All three resulting companies are anticipated to have strong balance sheets and sufficient capitalization to pursue future growth opportunities.Softness in Specific Businesses a Concern for DD StockDuPont faces headwinds from demand weakness in certain businesses. The Industrial Solutions business is exposed to volume pressure within the Kalrez business. Organic sales in Industrial Solutions declined year over year in the third quarter due to lower volumes. Headwinds from de-stocking in the Kalrez business are expected to continue in the fourth quarter. While DuPont is seeing a recovery lately, additional volume pressure within its industrial-based businesses is expected to continue in the fourth quarter.DD is also seeing lower sales in safety solutions. Organic sales in this business were down by mid-single digits in the third quarter on lower prices and volumes. The business saw lower volumes due to declines in Tyvek medical packaging. The shelter solutions business is also facing headwinds in North American residential construction markets, which is impacting sales. Despite a recovery, volume pressure in these businesses is likely to continue in the fourth quarter.DuPont de Nemours, Inc. Price and Consensus DuPont de Nemours, Inc. price-consensus-chart | DuPont de Nemours, Inc. QuoteDD’s Zacks Rank & Key PicksDD currently carries a Zacks Rank #3 (Hold).Better-ranked stocks in the Basic Materials space are Carpenter Technology Corporation CRS, ICL Group Ltd ICL and ATI Inc. ATI. While CRS sports a Zacks Rank #1 (Strong Buy), both ICL and ATI carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.Carpenter Technology beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 14.1%. CRS’ shares have soared 174% in the past year. The Zacks Consensus Estimate for ICL Group’s current-year earnings has increased by 2.9% in the past 60 days. ICL beat the consensus estimate in each of the last four quarters with the average surprise being 18.1%. ATI beat the consensus estimate in three of the last four quarters while missing once. In this time frame, it has delivered an earnings surprise of roughly 3.7%, on average. ATI has gained around 30% in the past year.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ATI Inc. (ATI): Free Stock Analysis Report DuPont de Nemours, Inc. (DD): Free Stock Analysis Report Carpenter Technology Corporation (CRS): Free Stock Analysis Report ICL Group Ltd. (ICL): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf DuPont de Nemours

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf DuPont de Nemours

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu DuPont de Nemours

Wer­bung

Analysen zu DuPont de Nemours

DatumRatingAnalyst
04.10.2021DuPont de Nemours OverweightJP Morgan Chase & Co.
20.08.2019DowDuPont OutperformCowen and Company, LLC
25.06.2019DowDuPont NeutralMonness, Crespi, Hardt & Co.
10.06.2019DowDuPont OutperformCowen and Company, LLC
06.02.2019DowDuPont Market PerformCowen and Company, LLC
DatumRatingAnalyst
04.10.2021DuPont de Nemours OverweightJP Morgan Chase & Co.
20.08.2019DowDuPont OutperformCowen and Company, LLC
10.06.2019DowDuPont OutperformCowen and Company, LLC
12.10.2018DowDuPont buyDeutsche Bank AG
29.03.2018DowDuPont OutperformBMO Capital Markets
DatumRatingAnalyst
25.06.2019DowDuPont NeutralMonness, Crespi, Hardt & Co.
06.02.2019DowDuPont Market PerformCowen and Company, LLC
12.09.2017DowDuPont NeutralMonness, Crespi, Hardt & Co.
31.05.2017Dow Chemical Market PerformCowen and Company, LLC
26.04.2017DuPont (E I DuPont de Nemours and Sector PerformRBC Capital Markets
DatumRatingAnalyst
05.01.2009Dow Chemical verkaufenEuro am Sonntag
11.04.2007Dow Chemical verkaufenHamburger Sparkasse
03.02.2006Update Rohm and Haas Co.: ReduceUBS
07.07.2005Update Rohm and Haas Co.: SellLongbow

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für DuPont de Nemours nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"